Fresenius Medical Care Stock Current Asset
| FMCQF Stock | USD 46.52 0.00 0.00% |
Fundamental analysis of Fresenius Medical allows traders to better anticipate movements in Fresenius Medical's stock price by examining its financial health and performance throughout various phases of its business cycle.
Fresenius |
Fresenius Medical Care Company Current Asset Analysis
Fresenius Medical's Current Asset is all of the company's assets that can be used to pay off current liabilities within the current fiscal period or over the next 12 months. Current Asset includes cash or cash equivalents, accounts receivable, short-term investments, and the portion of prepaid liabilities which will be paid within the next 12 months. Because these assets are easily turned into cash, they are sometimes referred to as liquid assets.
Current Fresenius Medical Current Asset | 7.22 B |
Most of Fresenius Medical's fundamental indicators, such as Current Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Fresenius Medical Care is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Current Asset is important to company's creditors and private equity firms as they will often be interested in how much that company has in current assets since these assets can be easily liquidated in case the company goes bankrupt. However, it is usually not enough to know if a company is in good shape just based on current asset alone; the amount of current liabilities should always be considered.
| Competition |
In accordance with the recently published financial statements, Fresenius Medical Care has a Current Asset of 7.22 B. This is 235.43% higher than that of the Healthcare sector and significantly higher than that of the Medical Care Facilities industry. The current asset for all United States stocks is 22.7% higher than that of the company.
Fresenius Current Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Fresenius Medical's direct or indirect competition against its Current Asset to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Fresenius Medical could also be used in its relative valuation, which is a method of valuing Fresenius Medical by comparing valuation metrics of similar companies.Fresenius Medical is currently under evaluation in current asset category among its peers.
Fresenius Fundamentals
| Return On Equity | 0.0666 | |||
| Return On Asset | 0.0253 | |||
| Profit Margin | 0.04 % | |||
| Operating Margin | 0.08 % | |||
| Current Valuation | 22.64 B | |||
| Shares Outstanding | 293.41 M | |||
| Shares Owned By Insiders | 32.16 % | |||
| Shares Owned By Institutions | 38.34 % | |||
| Price To Earning | 11.60 X | |||
| Price To Book | 0.58 X | |||
| Price To Sales | 0.49 X | |||
| Revenue | 17.62 B | |||
| Gross Profit | 5.08 B | |||
| EBITDA | 1.93 B | |||
| Net Income | 969.31 M | |||
| Cash And Equivalents | 1.11 B | |||
| Cash Per Share | 3.07 X | |||
| Total Debt | 6.65 B | |||
| Debt To Equity | 0.82 % | |||
| Current Ratio | 1.34 X | |||
| Book Value Per Share | 41.54 X | |||
| Cash Flow From Operations | 2.49 B | |||
| Earnings Per Share | 2.79 X | |||
| Price To Earnings To Growth | 1.04 X | |||
| Number Of Employees | 122.76 K | |||
| Beta | 0.9 | |||
| Market Capitalization | 11.24 B | |||
| Total Asset | 34.37 B | |||
| Retained Earnings | 8.45 B | |||
| Working Capital | 1.96 B | |||
| Current Asset | 7.22 B | |||
| Current Liabilities | 5.25 B | |||
| Z Score | 0.6 | |||
| Annual Yield | 0.04 % | |||
| Five Year Return | 1.30 % | |||
| Net Asset | 34.37 B | |||
| Last Dividend Paid | 1.35 |
About Fresenius Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Fresenius Medical Care's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Fresenius Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Fresenius Medical Care based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| PRNEX | T Rowe Price | |
| RPBAX | T Rowe Price | |
| PRDGX | T Rowe Price | |
| PRFDX | T Rowe Price | |
| RPBAX | T Rowe Price |
Additional Information and Resources on Investing in Fresenius Pink Sheet
When determining whether Fresenius Medical Care is a strong investment it is important to analyze Fresenius Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Fresenius Medical's future performance. For an informed investment choice regarding Fresenius Pink Sheet, refer to the following important reports:Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Fresenius Medical Care. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in producer price index. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.